Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 26, 2011
- Accepted September 12, 2011
- Published online November 21, 2011.
Article Versions
- Earlier version (September 12, 2011 - 10:26).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- S. M. Jenkins,
- T. Zvyaga,
- S. R. Johnson,
- J. Hurley,
- A. Wagner,
- R. Burrell,
- W. Turley,
- J. E. Leet,
- T. Philip and
- A. D. Rodrigues
- Bristol-Myers Squibb Molecular Sciences & Candidate Optimization, Wallingford, Connecticut (S.M.J., T.Z., J.H., A.W., R.B., W.T., J.E.L., T.P.); and Bristol-Myers Squibb Molecular Sciences & Candidate Optimization, Princeton, New Jersey (S.R.J., A.D.R.)
- Address correspondence to:
Dr. Susan M. Jenkins, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492. E-mail: susan.jenkins{at}bms.com
Statistics from Altmetric.com
Article usage
In this issue
INHIBITION OF CYP2C8 BY GEMFIBROZIL GLUCURONIDE ANALOGS
